ENDS IN
Get Your Press Releases for up to 70% off ONLY in September! Save Now
MarketersMEDIA / Newsroom / Global Renal Denervation Market is Predicted to Register CAGR of 40.4% by 2023, Says MRFR

Global Renal Denervation Market is Predicted to Register CAGR of 40.4% by 2023, Says MRFR

Share This Press Release

Global Renal Denervation Market Research Report: by Product (Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis), by Technology (Radiofrequency, Ultrasound, Micro-infusion), by End-user (Hospitals, Clinics, Ambulatory Surgical Centers), and Region - Forecast To 2023

— Global Renal Denervation Market- Overview
According to Market Research Future (MRFR), the global renal denervation market is estimated to rise at a CAGR of 40.4% over the 2018-2023 forecast period, with the valuation rising from USD 200 million in 2017 to USD 2,850 million in 2023.
Renal denervation is a minimally invasive procedure for the treatment of resistant hypertension. The process uses RF or ultrasound nerve ablation in the renal artery to lessen sympathetic activity in the kidney and reduce blood pressure.

FREE SAMPLE COPY OF “Renal Denervation Market Research Report- Global forecast till 2023”@ https://www.marketresearchfuture.com/sample_request/6712

Global Renal Denervation Market Dynamics
The global renal denervation market is primarily driven by the growing prevalence of hypertension worldwide. As per the CDC, the incidence of hypertension was close to 26% among 20 years of age or older in 2000. In the next ten years, the incidence of hypertension has increased by 5.2%, making it a significant problem for the healthcare system in countries across the globe. Developed countries have successfully taken steps to combat and minimize the prevalence of hypertension in their population, leading to increased demand for the renal denervation sector.

Another key driver for the global market for renal denervation is the increasing awareness among people in developing countries and the sustained growth of the healthcare infrastructure in Asia Pacific. In recent years, Asian Pacific countries have taken significant measures to close the gap between themselves and the developed western countries in terms of technical development and sophistication of their healthcare sectors. Countries such as China and India have launched significant initiatives to help the development of the healthcare sector, contributing to steady growth in the renal denervation industry. The steady growth of the healthcare infrastructure in APAC countries is likely to be a significant driver of the renal denervation market over the forecast period, as hypertension is on the rise in Southeast Asian countries and requires preventive steps to keep it under control.
Increased preference for minimally invasive procedures among the population is also a significant driver of renal denervation. Risk minimization obtained in minimally invasive procedures has made them popular among customers, and governments are now supporting the increasing adoption of minimally invasive procedures by making it easier to integrate minimally invasive procedures into the healthcare sector's processes. This is likely to be a significant driver of the global market for renal denervation over the forecast period.

Global Renal Denervation Market Segmentation
The global market for renal denervation market has been segmented based on the product, technology, and end-use.
By product, the global market for renal denervation market has been segmented into Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and others. Symplicity owns the largest market share in the renal denervation market and is expected to remain a significant contributor over the forecast period. However, over the forecast era, Paradise is expected to be the fastest-growing segment of the renal denervation industry.

By technology, the global market for renal denervation market has been segmented into radiofrequency, ultrasound, micro-infusion, and others. Radiofrequency is expected to be the fastest-growing segment in the forecast period, eclipsing ultrasound, currently the largest market segment, in terms of growth rate.
By the end-use, the global market for renal denervation has been segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are the largest segment of the global market for renal denervation, while ambulatory surgical centers are projected to show the fastest growth in the forecast era.

Global Renal Denervation Market Regional Analysis
By region, the global market for renal denervation has been segmented into North America, Europe, Asia Pacific, and the Rest of the world.

Europe led the market for renal denervation in 2017 and is expected to remain dominant even throughout the forecast period. It is due to the growing R&D activities for the production of efficient equipment. Growing cases of drug-resistant hypertension would also lead to the growth of the region. As stated by the National Center for Biotechnology Information (NCBI) in the United Kingdom, hypertension cases increased from 3.79 cases per 100 people in 2000 to 6.46 cases per 100 in 2015. In addition, the approval of devices in the European region is also expected to support business growth.
North America is expected to follow Europe in terms of revenue generation during the forecast period due to the growing number of FDA approval filings in the U.S. For example, Medtronic has obtained FDA approval to launch a critical investigational product exemption (IDE) trial to test the Symplicity Spyral renal denervation system in patients with hypertension. Increased incidence of uncontrolled hypertension is also one of the main factors responsible for the region's development.
Asia Pacific is expected to see the highest growth in the forecast period due to growing cases of diabetes, obesity, and other lifestyle diseases. In addition, the emergence of a large target population base in emerging economies such as Japan and China are the primary driver of APAC market growth.

Global Renal Denervation Market Key Players
Some of the leading participants in the global renal denervation market include Medtronic, Boston Scientific, St. Jude Medical, Cardiosonic, Cordis, ReCor Medical Sound Intervention, Kona Medical, and Terumo.

OBTAIN RESEARCH REPORT DETAILS WITH Covid19 Impact on this report @ https://www.marketresearchfuture.com/reports/renal-denervation-market-6712

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: WantStats Research and Media Pvt. Ltd. Office No. 528, Amanora Chambers
Phone: 06468459312
Website: https://www.marketresearchfuture.com/sample_request/6712

Source URL: https://marketersmedia.com/global-renal-denervation-market-is-predicted-to-register-cagr-of-404-by-2023-says-mrfr/88966275

Source: MarketersMedia

Release ID: 88966275

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2020 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).